<?xml version='1.0' encoding='utf-8'?>
<document id="22959733"><sentence text="Reducing cost by reducing polypharmacy: the polypharmacy outcomes project." /><sentence text="To examine the effect of intervention by geriatric medicine fellows and a geriatrician on medication cost among long term care residents with polypharmacy" /><sentence text="" /><sentence text="Interventional study" /><sentence text="" /><sentence text="A single hospital-affiliated long term care facility" /><sentence text="" /><sentence text="Long term care residents with polypharmacy, defined as being on 9 or more medications" /><sentence text="" /><sentence text="Medication lists of all nursing home residents were reviewed in October 2007 by geriatric medicine fellows and a faculty geriatrician using the 2003 Beers Criteria and the Epocrates online drug-drug interaction program" /><sentence text=" Recommendations for each resident were prepared and discussed directly with their primary physicians, who made the final decisions regarding medication discontinuation or taper" /><sentence text="" /><sentence text="Mean monthly costs (derived from current retail prices) for overall as well as scheduled and pro re nata (PRN) medications were compared before and after the intervention" /><sentence text=" Estimated reduction in nursing administration time and cost were calculated based on published literature on medication administration time and nursing labor costs" /><sentence text="" /><sentence text="Seventy-four (46" /><sentence text="3%) of 160 residents were on 9 or more medications" /><sentence text=" Four residents died or were discharged before the intervention, leaving a final sample of 70 residents for the intervention" /><sentence text=" After the intervention, mean monthly medication costs per resident significantly decreased; overall medications, from $874" /><sentence text="27 to $843" /><sentence text="56 (P &lt; " /><sentence text="0001); scheduled medications, from $814" /><sentence text="05 to $801" /><sentence text="14 (P= " /><sentence text="007); PRN medications, from $60" /><sentence text="22 to $42" /><sentence text="43 (P &lt; " /><sentence text="0001)" /><sentence text=" Gastrointestinal medications demonstrated the highest cost savings of all medication categories (eg, promethazine and proton pump inhibitors), followed by central nervous system-active medications (including benzodiazepines and fluoxetine), then analgesics and diabetes medications"><entity charOffset="102-114" id="DDI-PubMed.22959733.s29.e0" text="promethazine" /><entity charOffset="209-224" id="DDI-PubMed.22959733.s29.e1" text="benzodiazepines" /><entity charOffset="229-239" id="DDI-PubMed.22959733.s29.e2" text="fluoxetine" /><pair ddi="false" e1="DDI-PubMed.22959733.s29.e0" e2="DDI-PubMed.22959733.s29.e0" /><pair ddi="false" e1="DDI-PubMed.22959733.s29.e0" e2="DDI-PubMed.22959733.s29.e1" /><pair ddi="false" e1="DDI-PubMed.22959733.s29.e0" e2="DDI-PubMed.22959733.s29.e2" /><pair ddi="false" e1="DDI-PubMed.22959733.s29.e1" e2="DDI-PubMed.22959733.s29.e1" /><pair ddi="false" e1="DDI-PubMed.22959733.s29.e1" e2="DDI-PubMed.22959733.s29.e2" /></sentence><sentence text="" /><sentence text="This polypharmacy reduction intervention by physicians used readily available tools, demonstrated a significant decrease in medication-related costs, and provided training in the core competencies of practice-based learning and improvement and systems-based practice to geriatric medicine fellows in long term care" /><sentence text="" /></document>